28 related articles for article (PubMed ID: 28739731)
1. Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis.
Kim M; Lee HH; Won SD; Jang Y; Kim BG; Cho NH; Choi YD; Chung JS; Han HH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276060
[TBL] [Abstract][Full Text] [Related]
2. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.
Zhang J; Kang J; Wu L
Turk J Med Sci; 2024; 54(1):26-32. PubMed ID: 38812622
[TBL] [Abstract][Full Text] [Related]
3. The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC.
Qi X; Li Q; Che X; Wang Q; Wu G
Front Oncol; 2021; 11():727778. PubMed ID: 34604067
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma.
Ni JS; Zheng H; Huang ZP; Hong YG; Ou YL; Tao YP; Wang MC; Wang ZG; Yang Y; Zhou WP
Oncol Lett; 2019 Feb; 17(2):2317-2327. PubMed ID: 30675297
[TBL] [Abstract][Full Text] [Related]
5. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth inhibitor 174 and its functional domains inhibit epithelial-mesenchymal transition in renal cell carcinoma cells in vitro.
Zhang N; Hong B; Lian W; Zhou C; Chen S; Du X; Deng X; Duoerkun S; Li Q; Yang Y; Gong K
Int J Mol Med; 2017 Aug; 40(2):569-575. PubMed ID: 28656288
[TBL] [Abstract][Full Text] [Related]
7. Protein of Vascular Endothelial Growth Inhibitor 174 Inhibits Epithelial-Mesenchymal Transition in Renal Cell Carcinoma
Zhao Q; Deng X; Hong B; Wang F; Tang X; Yang Y; Gong K; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4269-4275. PubMed ID: 28739718
[TBL] [Abstract][Full Text] [Related]
8. Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
Zhang N; Wu P; Shayiremu D; Wu L; Shan H; Ye L; Zhao X; Cai J; Jiang WG; Gong K; Yang Y
Int J Oncol; 2013 May; 42(5):1664-73. PubMed ID: 23545578
[TBL] [Abstract][Full Text] [Related]
9. VEGI174 protein and its functional domain peptides exert antitumour effects on renal cell carcinoma.
Zhao Q; Hong B; Liu T; Ji Y; Tang X; Gong K; Ye L; Yang Y; Zhang N
Int J Oncol; 2019 Jan; 54(1):390-398. PubMed ID: 30431089
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Proteins Interacting with Vascular Endothelial Growth Inhibitor 174 in Renal Cell Carcinoma.
Zhao Q; Kun D; Hong B; Deng X; Guo S; Tang X; Yang Y; Gong K; Li Q; Ye L; Jiang WG; Zhang N
Anticancer Res; 2017 Aug; 37(8):4379-4388. PubMed ID: 28739731
[TBL] [Abstract][Full Text] [Related]
11. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma.
Rini BI; Rathmell WK
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):741s-746s. PubMed ID: 17255303
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth inhibitor in human cancer (Review).
Zhang N; Sanders AJ; Ye L; Jiang WG
Int J Mol Med; 2009 Jul; 24(1):3-8. PubMed ID: 19513527
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
